NCT02550756View on ClinicalTrials.gov

Study to Evaluate the Safety and Tolerability of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

November 30, 2014

Conditions
Morton's Neuroma
Interventions
DRUG

CTNX-4975

Sponsors
All Listed Sponsors
lead

Centrexion Therapeutics

INDUSTRY